You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,021,456


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,021,456
Title:Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
Abstract: Disclosed are beta and gamma-amino isoquinoline amide compounds and substituted benzamide compounds. In particular, the invention provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. The compounds of the invention are useful in the treatment of a variety of diseases and conditions including eye diseases such as glaucoma, cardiovascular diseases, and diseases characterized by abnormal growth, such as cancers. The invention further provides compositions containing the beta or gamma-amino isoquinoline amide compounds or substituted benzamide compounds.
Inventor(s): deLong; Mitchell A. (Chapel Hill, NC), Sturdivant; Jill Marie (Chapel Hill, NC), Royalty; Susan M. (Davis, CA)
Assignee: Aerie Pharmaceuticals, Inc. (Bedminster, NJ)
Application Number:16/730,085
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,021,456

To delve into the specifics of United States Patent 11,021,456, it is crucial to analyze the patent's claims, the underlying technology, and the broader patent landscape. Here is a detailed breakdown of the key aspects.

Patent Overview

United States Patent 11,021,456, like any other patent, is a grant of rights for an invention, and its scope is defined by its claims. The claims are the legal boundaries of what the patent protects.

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[5].

Claim Structure

Each claim must be carefully crafted to meet the criteria for patent eligibility. This involves ensuring that the claims integrate judicial exceptions (such as abstract ideas or natural phenomena) into practical applications. For instance, if a claim involves an abstract idea, it must include additional elements that impose meaningful limits on the exception, transforming it into patent-eligible subject matter[1].

Examples from Recent Guidance

The 2024 USPTO guidance update provides examples that illustrate how claims can be made patent-eligible. For example, a claim that merely uses a mathematical model to manipulate data without any practical application would be ineligible. However, if the claim specifies the use of the data in a real-time speech recognition system to enhance accuracy, it becomes eligible due to the practical application[1].

Subject Matter Eligibility

Judicial Exceptions

Claims must avoid being categorized as mere abstract ideas, laws of nature, or natural phenomena. If a claim involves such exceptions, it must include additional elements that integrate these exceptions into a practical application. This is a critical step in ensuring the claim is patent-eligible[1].

Practical Applications

The patent must demonstrate how the claimed invention provides concrete benefits or solves specific problems in the relevant field. For example, if the patent claims a method for improving speech recognition accuracy in hands-free environments, it must specify how this method is applied in a practical way to achieve tangible benefits[1].

Patent Landscape

Prior Art and Novelty

To be granted, a patent must be novel and non-obvious over the prior art. This involves a thorough search of existing patents and publications to ensure the invention is new and not an obvious variation of what already exists. Tools like the USPTO's Patent Public Search and Global Dossier can be used to conduct such searches[4].

International Considerations

The patent landscape is not limited to the United States. Inventors and patent holders must also consider international patent databases and offices, such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), to ensure their invention is novel globally[4].

Economic and Legal Implications

Patent Scope and Economic Impact

The scope of a patent, as defined by its claims, can significantly impact its economic value. Broader claims can provide more extensive protection but may face more challenges during the examination process. Narrower claims, while more easily granted, may offer less protection. The USPTO's Patent Claims Research Dataset can provide insights into the scope and economic impact of patents[3].

Legal Defenses and Presumption of Validity

Once granted, a patent is presumed valid under 35 USC 282. However, this does not mean it is immune to challenges. Defenses against patent infringement claims can include arguments that the patent is invalid due to lack of novelty, non-obviousness, or other grounds[5].

AI-Assisted Inventions

Role of AI in Patent Eligibility

The 2024 USPTO guidance update clarifies that the use of AI in developing an invention does not affect its subject matter eligibility. What matters is the claimed invention itself and whether it integrates judicial exceptions into practical applications. This ensures that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Real-World Applications

Tangible Benefits

To be patent-eligible, the claimed invention must provide tangible benefits or solve specific problems in the relevant field. For instance, if a patent claims a method for improving audio processing, it must demonstrate how this method enhances the technology in a practical way, such as through improved noise reduction or accuracy in real-time speech recognition[1].

Consultation and Resources

USPTO Resources

Inventors and patent practitioners can utilize various USPTO resources, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs), to ensure their claims are well-crafted and the invention is novel[4].

Expert Consultation

Consulting with experts, such as those involved in the ACUS study on small claims patent courts, can provide valuable insights into the legal and practical considerations of patenting an invention[2].

Key Takeaways

  • Claims Must Integrate Judicial Exceptions: Claims must integrate abstract ideas or other judicial exceptions into practical applications to be patent-eligible.
  • Practical Applications Are Crucial: The claimed invention must provide tangible benefits or solve specific problems in the relevant field.
  • AI-Assisted Inventions Are Evaluated Equally: The use of AI in developing an invention does not impact its subject matter eligibility.
  • Thorough Search of Prior Art: Ensuring the invention is novel over prior art is essential for patent grant.
  • International Considerations: The global patent landscape must be considered to ensure the invention is novel and protected internationally.

FAQs

Q: What is the significance of integrating judicial exceptions into practical applications in patent claims?

A: Integrating judicial exceptions into practical applications ensures that the claim is transformed into patent-eligible subject matter, providing a meaningful limit and tangible benefits.

Q: How does the use of AI impact the patent eligibility of an invention?

A: The use of AI in developing an invention does not affect its subject matter eligibility. The focus remains on the claimed invention itself and whether it integrates judicial exceptions into practical applications.

Q: What resources can inventors use to ensure their patent claims are well-crafted?

A: Inventors can use USPTO resources such as the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) to ensure their claims are well-crafted.

Q: Why is it important to demonstrate real-world applications of the claimed invention?

A: Demonstrating real-world applications is crucial because it shows how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field.

Q: What is the role of prior art in the patent examination process?

A: Prior art is essential in determining the novelty and non-obviousness of the invention. A thorough search of prior art ensures that the invention is new and not an obvious variation of what already exists.

Cited Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz.
  2. U.S. Patent Small Claims Court - ACUS.
  3. Patent Claims Research Dataset - USPTO.
  4. Search for patents - USPTO - USPTO.
  5. 35 USC 282: Presumption of validity; defenses - US Code.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,021,456

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alcon Labs Inc RHOPRESSA netarsudil mesylate SOLUTION/DROPS;OPHTHALMIC 208254-001 Dec 18, 2017 RX Yes Yes 11,021,456 ⤷  Subscribe REDUCTION OF ELEVATED INTRAOCULAR PRESSURE ⤷  Subscribe
Alcon Labs Inc ROCKLATAN latanoprost; netarsudil dimesylate SOLUTION/DROPS;OPHTHALMIC 208259-001 Mar 12, 2019 RX Yes Yes 11,021,456 ⤷  Subscribe REDUCTION OF ELEVATED INTRAOCULAR PRESSURE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,021,456

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009273932 ⤷  Subscribe
Canada 2731869 ⤷  Subscribe
European Patent Office 2326623 ⤷  Subscribe
Spain 2474150 ⤷  Subscribe
Japan 2011529074 ⤷  Subscribe
Japan 2014208681 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.